Masim, Mishelle Anggy O.
HRN: 23-01-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2023
CEFTRIAXONE 1G (VIAL)
05/15/2023
05/21/2023
IV
2gm
Q24
Cap MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes